Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12500 participants
INTERVENTIONAL
2021-12-29
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study
NCT04508556
POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test
NCT04981769
The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study
NCT04868864
Capturing Infectious COVID-19 Asymptomatic Cases in Singapore
NCT04812327
Communities Fighting COVID-19!
NCT05148936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All individuals (3yrs or older) presenting to designated hospital COVID-19 Assessment Centres in Ottawa will be recruited to participate. Only people with extreme fingertip scarring will be excluded. Consenting participants will undergo a scan using the SpotLight-19 device - this includes a Fitzpatrick Skin Assessment and 10-20 second scans of the fingertip with the SpotLight-19 device. Following the scan participants will undergo a PCR test as per usual care. The PCR result, participant age, COVID-19 vaccination status, and presence of COVID-19 symptoms will be collected from the medical record and shared with ISBRG Corp. A minimum of 250 COVID-19 positive and a minimum of 250 COVID-19 negative as determined by PCR will be sought. The number of enrolled participants to achieve the sample size will depend on the COVID-19 positivity rate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spectral scan (All participants)
1. Fitzpatrick skin assessment.
2. Fingertip scanned using the SpotLight-19 device. The scan is approximately 10-20 seconds. Participants will not feel any sensation from the device, i.e., no heat, no pain, no cold, no vibration or pressure.
3. Information collected from the medical record regarding participant age, COVID-19 vaccination status, presence of COVID-19 symptoms, and PCR test result.
Spectral scan
Consenting participants will have a SpotLight-19 scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectral scan
Consenting participants will have a SpotLight-19 scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is capable of cooperating with testing
* Is clinically stable such that the testing protocol may be completed safely
Exclusion Criteria
3 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ISBRG Corp
OTHER
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alan Forster
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rae Lake, MD
Role: PRINCIPAL_INVESTIGATOR
ISBRG Corp
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
COVID-19 CHEO Assessment Centre
Ottawa, Ontario, Canada
COVID-19 Assessment Centre for Adults
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nadine Drosdowech
Role: primary
Cassie Matthews
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20210902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.